FDA Inspection
JW Pharmaceutical Corporation - Sihwa PlantJW Pharmaceutical Corporation - Sihwa Plant – FDA Inspection, Mar 17, 2023
Record Details
This FDA Inspection record concerns JW Pharmaceutical Corporation - Sihwa Plant, with an inspection on March 17, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 46400ce4-fe9a-44d1-84ad-d2c3ae93f166
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1201702
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of JW Pharmaceutical Corporation - Sihwa Plant
1| Date | Classification | Office | Project area |
|---|---|---|---|
| October 26, 2018 | Not classified | Office of Inspections and Investigations |
Other documents for JW Pharmaceutical Corporation - Sihwa Plant
- FDA Inspection 1072631 - 2018-10-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.